ArticleNeuroradiology2025
MRA evaluation of aneurysms treated with woven endobridge (WEB) devices or coils: an inter- and intra-observer reliability study.
Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMagnetic resonance angiography (MRA) is a commonly used non-invasive imaging modality for the follow-up of treated intracranial aneurysms. The 3-category Montreal classification system is widely used to evaluate treatment outcomes, including aneurysms treated with Woven EndoBridge (WEB) devices or coils. This study aimed to assess the reliability and clinical implications of the Montreal scale for aneurysms imaged with MRA.
methodsAn electronic portfolio of 60 aneurysms (30 treated with WEB devices and 30 with coils) was evaluated by 30 raters from diverse clinical backgrounds. Raters graded aneurysm occlusion using the Montreal classification system and provided management recommendations (delayed follow-up, close follow-up, or re-treatment). Twenty-three raters completed a second evaluation of permuted cases after one month. Reliability was assessed using Gwet's AC2 (κG) coefficients, and the correlation between occlusion grade and management recommendation was analyzed with Cramer's V.
resultsInter-rater agreement for occlusion grades was substantial (κG = 0.70; 95% CI: 0.66-0.75) and similar for WEB-treated (κG = 0.66; 95% CI: 0.59-0.74) and coiled aneurysms (κG = 0.75; 95% CI: 0.68-0.82). Management decisions showed substantial agreement overall (κG = 0.68; 95% CI: 0.60-0.76). Mean intra-rater agreement was almost perfect (κG = 0.84 ± 0.06). Strong correlations were observed between occlusion grades and management recommendations (mean Cramer's V = 0.78 ± 0.13), with consistent management strategies across treatment modalities.
conclusionThe Montreal scale demonstrated substantial reliability and clinical relevance for evaluating aneurysms treated with WEB or coils using MRA, supporting its use in non-invasive follow-up protocols.
Indexed as
Identifiers
40694083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.